Showing results (111-120 of 277) with videos related to

Sort By:
Pageof 28
Frontiers in Microbiology|June 6, 2018
Genomic Variations in Probiotic <i>Lactobacillus plantarum</i> P-8 in the Human and Rat GutYuqin Song, Qiuwen He, Jiachao Zhang, et al.
Mbio|June 22, 2026
<i>Webervirus</i> phages exploit capsule- and O-antigen-targeting receptor-binding proteins to access diverse <i>Klebsiella pneumoniae</i> hostsZixuan Ding, Yongqi Mu, Wenyue Sun, et al.
Genome Announcements|April 30, 2016
Draft Genome Sequence of "Paramesorhizobium deserti" A-3-ET, a Strain Highly Resistant to Diverse β-Lactam AntibioticsRuichen Lv, Xianwei Yang, Nan Fang, et al.
Targeted Oncology|March 25, 2019
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter StudyXiaonan Hong, Yuqin Song, Huiqiang Huang, et al.
Oncotarget|May 7, 2015
Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphomaNing Ding, Xitao Li, Yunfei Shi, et al.
Molecular Therapy Oncolytics|May 13, 2021
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphomaHui Yu, Xing Wang, Jiao Li, et al.
Frontiers in Oncology|September 8, 2022
Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral eraReyizha Nuersulitan, Miaomiao Li, Lan Mi, et al.
Microbiology Spectrum|February 24, 2022
Molecular Characterization of WCK 5222 (Cefepime/Zidebactam)-Resistant Mutants Developed from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical IsolateXiaolei Pan, Xinrui Zhao, Yuqin Song, et al.
International Journal of Cancer|September 15, 2017
The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphomaJiao Li, Xiaogan Wang, Yan Xie, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 15, 2022
The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell LymphomaJiao Li, Hui Yu, Xing Wang, et al.
Pageof 28